Suchergebnisse - "Lauseker, Michael"

PubPharm (11)

1

Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry

enthalten in: Leukemia | 2024

von Brioli, A. | Lomaia, E. | Fabisch, C. | +35

2

Survival with chronic myeloid leukaemia after failing milestones

enthalten in: Leukemia | 2023

von Lauseker, M. | Hehlmann, R. | Hochhaus, A. | +1

CommentIn: Leukemia. 2023 Oct 5;:. - PMID 37798329

3

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

enthalten in: Leukemia | 2020

von Pfirrmann, M. | Clark, R. | Prejzner, W. | +27

4

Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex : Results from a population-based study

enthalten in: European journal of haematology | 2019

von Lauseker, M. | Gerlach, R. | Worseg, W. | +4

5

The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance

enthalten in: Endocrine-related cancer | 2018

von Aristizabal Prada, E. | Spöttl, G. | Maurer, J. | +8

6

The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors : Results from multiple cell line models

enthalten in: PloS one | 2017

von Nölting, S. | Rentsch, J. | Freitag, H. | +15

7

Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death

enthalten in: Annals of hematology | 2015

von Pfirrmann, M. | Lauseker, M. | Hoffmann, V. | +1

8

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients : a subanalysis of the randomized CML-Study IV

enthalten in: Annals of hematology | 2014

von Proetel, U. | Pletsch, N. | Lauseker, M. | +124

9

Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib : results from the randomized CML-study IV

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Hehlmann, R. | Müller, M. | Lauseker, M. | +29

CommentIn: J Clin Oncol. 2014 Feb 10;32(5):471-4. - PMID 24297955

10

Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators : results from the randomized CML study IV

enthalten in: Annals of hematology | 2014

von Kalmanti, L. | Saussele, S. | Lauseker, M. | +25